Get Real Time Here
| Open3.380 | Close3.180 |
| Vol / Avg.1.269M / 871.745K | Mkt Cap422.824M |
| Day Range3.135 - 3.480 | 52 Wk Range1.795 - 4.500 |
Organogenesis Hldgs Stock (NASDAQ:ORGO), Quotes and News Summary
Organogenesis Hldgs Stock (NASDAQ: ORGO) stock price, news, charts, stock research, profile.
| Open3.380 | Close3.180 |
| Vol / Avg.1.269M / 871.745K | Mkt Cap422.824M |
| Day Range3.135 - 3.480 | 52 Wk Range1.795 - 4.500 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | 0.020 | 0.050 | 0.0300 | ||||
| REV | 115.100M | 117.316M | 2.216M |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-08-11 | Morgan Stanley | Drew Ranieri | Maintains | Equal-WeightEqual-Weight | Lowers | 5.00 | 3.00 |
| 2023-08-10 | BTIG | Ryan Zimmerman | Maintains | BuyBuy | Lowers | 10.00 | 4.00 |
| 2023-06-15 | Morgan Stanley | Drew Ranieri | Initiates Coverage On | Equal-Weight | Announces | - | 5.00 |
| 2023-05-24 | BTIG | Ryan Zimmerman | Upgrades | NeutralBuy | Announces | - | 10.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| ORGO | Organogenesis Hldgs | -5.01% | 422.8M |
| RNA | Avidity Biosciences | -3.96% | 466.8M |
| FDMT | 4D Molecular Therapeutics | 0.71% | 535.3M |
| CDNA | CareDx | -0.57% | 379.2M |
| ANAB | AnaptysBio | -0.22% | 476.8M |
How do I buy Organogenesis Hldgs (ORGO) stock?
You can purchase shares of Organogenesis Hldgs (NASDAQ: ORGO) through any online brokerage.
Who are Organogenesis Hldgs's (ORGO) competitors?
Other companies in Organogenesis Hldgs’s space includes: Avidity Biosciences (NASDAQ:RNA), 4D Molecular Therapeutics (NASDAQ:FDMT), CareDx (NASDAQ:CDNA), AnaptysBio (NASDAQ:ANAB) and Agenus (NASDAQ:AGEN).
What is the target price for Organogenesis Hldgs (ORGO) stock?
The latest price target for Organogenesis Hldgs (NASDAQ: ORGO) was reported by Morgan Stanley on Friday, August 11, 2023. The analyst firm set a price target for 3.00 expecting ORGO to fall to within 12 months (a possible -6.83% downside). 5 analyst firms have reported ratings in the last year.
Current Stock Price for Organogenesis Hldgs (ORGO)?
The stock price for Organogenesis Hldgs (NASDAQ: ORGO) is $3.22 last updated September 29, 2023 at 9:08 PM UTC.
Does Organogenesis Hldgs (ORGO) pay a dividend?
There is no dividend information for Organogenesis Hldgs.
When is Organogenesis Hldgs (NASDAQ:ORGO) reporting earnings?
Organogenesis Hldgs’s Q3 earnings are confirmed for Wednesday, November 8, 2023.
Is Organogenesis Hldgs (ORGO) going to split?
There is no upcoming split for Organogenesis Hldgs.
What sector and industry does Organogenesis Hldgs (ORGO) operate in?
Organogenesis Hldgs is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Organogenesis Hldgs Stock (NASDAQ:ORGO), Quotes and News Summary
Organogenesis Hldgs Stock (NASDAQ: ORGO) stock price, news, charts, stock research, profile.
| Open3.380 | Close3.180 |
| Vol / Avg.1.269M / 871.745K | Mkt Cap422.824M |
| Day Range3.135 - 3.480 | 52 Wk Range1.795 - 4.500 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | 0.020 | 0.050 | 0.0300 | ||||
| REV | 115.100M | 117.316M | 2.216M |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-08-11 | Morgan Stanley | Drew Ranieri | Maintains | Equal-WeightEqual-Weight | Lowers | 5.00 | 3.00 |
| 2023-08-10 | BTIG | Ryan Zimmerman | Maintains | BuyBuy | Lowers | 10.00 | 4.00 |
| 2023-06-15 | Morgan Stanley | Drew Ranieri | Initiates Coverage On | Equal-Weight | Announces | - | 5.00 |
| 2023-05-24 | BTIG | Ryan Zimmerman | Upgrades | NeutralBuy | Announces | - | 10.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| ORGO | Organogenesis Hldgs | -5.01% | 422.8M |
| RNA | Avidity Biosciences | -3.96% | 466.8M |
| FDMT | 4D Molecular Therapeutics | 0.71% | 535.3M |
| CDNA | CareDx | -0.57% | 379.2M |
| ANAB | AnaptysBio | -0.22% | 476.8M |
How do I buy Organogenesis Hldgs (ORGO) stock?
You can purchase shares of Organogenesis Hldgs (NASDAQ: ORGO) through any online brokerage.
Who are Organogenesis Hldgs's (ORGO) competitors?
Other companies in Organogenesis Hldgs’s space includes: Avidity Biosciences (NASDAQ:RNA), 4D Molecular Therapeutics (NASDAQ:FDMT), CareDx (NASDAQ:CDNA), AnaptysBio (NASDAQ:ANAB) and Agenus (NASDAQ:AGEN).
What is the target price for Organogenesis Hldgs (ORGO) stock?
The latest price target for Organogenesis Hldgs (NASDAQ: ORGO) was reported by Morgan Stanley on Friday, August 11, 2023. The analyst firm set a price target for 3.00 expecting ORGO to fall to within 12 months (a possible -6.83% downside). 5 analyst firms have reported ratings in the last year.
Current Stock Price for Organogenesis Hldgs (ORGO)?
The stock price for Organogenesis Hldgs (NASDAQ: ORGO) is $3.22 last updated September 29, 2023 at 9:08 PM UTC.
Does Organogenesis Hldgs (ORGO) pay a dividend?
There is no dividend information for Organogenesis Hldgs.
When is Organogenesis Hldgs (NASDAQ:ORGO) reporting earnings?
Organogenesis Hldgs’s Q3 earnings are confirmed for Wednesday, November 8, 2023.
Is Organogenesis Hldgs (ORGO) going to split?
There is no upcoming split for Organogenesis Hldgs.
What sector and industry does Organogenesis Hldgs (ORGO) operate in?
Organogenesis Hldgs is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Organogenesis Hldgs Stock (NASDAQ:ORGO), Quotes and News Summary
Organogenesis Hldgs Stock (NASDAQ: ORGO) stock price, news, charts, stock research, profile.
| Open3.380 | Close3.180 |
| Vol / Avg.1.269M / 871.745K | Mkt Cap422.824M |
| Day Range3.135 - 3.480 | 52 Wk Range1.795 - 4.500 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | 0.020 | 0.050 | 0.0300 | ||||
| REV | 115.100M | 117.316M | 2.216M |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-08-11 | Morgan Stanley | Drew Ranieri | Maintains | Equal-WeightEqual-Weight | Lowers | 5.00 | 3.00 |
| 2023-08-10 | BTIG | Ryan Zimmerman | Maintains | BuyBuy | Lowers | 10.00 | 4.00 |
| 2023-06-15 | Morgan Stanley | Drew Ranieri | Initiates Coverage On | Equal-Weight | Announces | - | 5.00 |
| 2023-05-24 | BTIG | Ryan Zimmerman | Upgrades | NeutralBuy | Announces | - | 10.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| ORGO | Organogenesis Hldgs | -5.01% | 422.8M |
| RNA | Avidity Biosciences | -3.96% | 466.8M |
| FDMT | 4D Molecular Therapeutics | 0.71% | 535.3M |
| CDNA | CareDx | -0.57% | 379.2M |
| ANAB | AnaptysBio | -0.22% | 476.8M |
How do I buy Organogenesis Hldgs (ORGO) stock?
You can purchase shares of Organogenesis Hldgs (NASDAQ: ORGO) through any online brokerage.
Who are Organogenesis Hldgs's (ORGO) competitors?
Other companies in Organogenesis Hldgs’s space includes: Avidity Biosciences (NASDAQ:RNA), 4D Molecular Therapeutics (NASDAQ:FDMT), CareDx (NASDAQ:CDNA), AnaptysBio (NASDAQ:ANAB) and Agenus (NASDAQ:AGEN).
What is the target price for Organogenesis Hldgs (ORGO) stock?
The latest price target for Organogenesis Hldgs (NASDAQ: ORGO) was reported by Morgan Stanley on Friday, August 11, 2023. The analyst firm set a price target for 3.00 expecting ORGO to fall to within 12 months (a possible -6.83% downside). 5 analyst firms have reported ratings in the last year.
Current Stock Price for Organogenesis Hldgs (ORGO)?
The stock price for Organogenesis Hldgs (NASDAQ: ORGO) is $3.22 last updated September 29, 2023 at 9:08 PM UTC.
Does Organogenesis Hldgs (ORGO) pay a dividend?
There is no dividend information for Organogenesis Hldgs.
When is Organogenesis Hldgs (NASDAQ:ORGO) reporting earnings?
Organogenesis Hldgs’s Q3 earnings are confirmed for Wednesday, November 8, 2023.
Is Organogenesis Hldgs (ORGO) going to split?
There is no upcoming split for Organogenesis Hldgs.
What sector and industry does Organogenesis Hldgs (ORGO) operate in?
Organogenesis Hldgs is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Organogenesis Hldgs Stock (NASDAQ:ORGO), Quotes and News Summary
Organogenesis Hldgs Stock (NASDAQ: ORGO) stock price, news, charts, stock research, profile.
| Open3.380 | Close3.180 |
| Vol / Avg.1.269M / 871.745K | Mkt Cap422.824M |
| Day Range3.135 - 3.480 | 52 Wk Range1.795 - 4.500 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | 0.020 | 0.050 | 0.0300 | ||||
| REV | 115.100M | 117.316M | 2.216M |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-08-11 | Morgan Stanley | Drew Ranieri | Maintains | Equal-WeightEqual-Weight | Lowers | 5.00 | 3.00 |
| 2023-08-10 | BTIG | Ryan Zimmerman | Maintains | BuyBuy | Lowers | 10.00 | 4.00 |
| 2023-06-15 | Morgan Stanley | Drew Ranieri | Initiates Coverage On | Equal-Weight | Announces | - | 5.00 |
| 2023-05-24 | BTIG | Ryan Zimmerman | Upgrades | NeutralBuy | Announces | - | 10.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| ORGO | Organogenesis Hldgs | -5.01% | 422.8M |
| RNA | Avidity Biosciences | -3.96% | 466.8M |
| FDMT | 4D Molecular Therapeutics | 0.71% | 535.3M |
| CDNA | CareDx | -0.57% | 379.2M |
| ANAB | AnaptysBio | -0.22% | 476.8M |
How do I buy Organogenesis Hldgs (ORGO) stock?
You can purchase shares of Organogenesis Hldgs (NASDAQ: ORGO) through any online brokerage.
Who are Organogenesis Hldgs's (ORGO) competitors?
Other companies in Organogenesis Hldgs’s space includes: Avidity Biosciences (NASDAQ:RNA), 4D Molecular Therapeutics (NASDAQ:FDMT), CareDx (NASDAQ:CDNA), AnaptysBio (NASDAQ:ANAB) and Agenus (NASDAQ:AGEN).
What is the target price for Organogenesis Hldgs (ORGO) stock?
The latest price target for Organogenesis Hldgs (NASDAQ: ORGO) was reported by Morgan Stanley on Friday, August 11, 2023. The analyst firm set a price target for 3.00 expecting ORGO to fall to within 12 months (a possible -6.83% downside). 5 analyst firms have reported ratings in the last year.
Current Stock Price for Organogenesis Hldgs (ORGO)?
The stock price for Organogenesis Hldgs (NASDAQ: ORGO) is $3.22 last updated September 29, 2023 at 9:08 PM UTC.
Does Organogenesis Hldgs (ORGO) pay a dividend?
There is no dividend information for Organogenesis Hldgs.
When is Organogenesis Hldgs (NASDAQ:ORGO) reporting earnings?
Organogenesis Hldgs’s Q3 earnings are confirmed for Wednesday, November 8, 2023.
Is Organogenesis Hldgs (ORGO) going to split?
There is no upcoming split for Organogenesis Hldgs.
What sector and industry does Organogenesis Hldgs (ORGO) operate in?
Organogenesis Hldgs is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Organogenesis Hldgs Stock (NASDAQ:ORGO), Quotes and News Summary
Organogenesis Hldgs Stock (NASDAQ: ORGO) stock price, news, charts, stock research, profile.
| Open3.380 | Close3.180 |
| Vol / Avg.1.269M / 871.745K | Mkt Cap422.824M |
| Day Range3.135 - 3.480 | 52 Wk Range1.795 - 4.500 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | 0.020 | 0.050 | 0.0300 | ||||
| REV | 115.100M | 117.316M | 2.216M |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-08-11 | Morgan Stanley | Drew Ranieri | Maintains | Equal-WeightEqual-Weight | Lowers | 5.00 | 3.00 |
| 2023-08-10 | BTIG | Ryan Zimmerman | Maintains | BuyBuy | Lowers | 10.00 | 4.00 |
| 2023-06-15 | Morgan Stanley | Drew Ranieri | Initiates Coverage On | Equal-Weight | Announces | - | 5.00 |
| 2023-05-24 | BTIG | Ryan Zimmerman | Upgrades | NeutralBuy | Announces | - | 10.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| ORGO | Organogenesis Hldgs | -5.01% | 422.8M |
| RNA | Avidity Biosciences | -3.96% | 466.8M |
| FDMT | 4D Molecular Therapeutics | 0.71% | 535.3M |
| CDNA | CareDx | -0.57% | 379.2M |
| ANAB | AnaptysBio | -0.22% | 476.8M |
How do I buy Organogenesis Hldgs (ORGO) stock?
You can purchase shares of Organogenesis Hldgs (NASDAQ: ORGO) through any online brokerage.
Who are Organogenesis Hldgs's (ORGO) competitors?
Other companies in Organogenesis Hldgs’s space includes: Avidity Biosciences (NASDAQ:RNA), 4D Molecular Therapeutics (NASDAQ:FDMT), CareDx (NASDAQ:CDNA), AnaptysBio (NASDAQ:ANAB) and Agenus (NASDAQ:AGEN).
What is the target price for Organogenesis Hldgs (ORGO) stock?
The latest price target for Organogenesis Hldgs (NASDAQ: ORGO) was reported by Morgan Stanley on Friday, August 11, 2023. The analyst firm set a price target for 3.00 expecting ORGO to fall to within 12 months (a possible -6.83% downside). 5 analyst firms have reported ratings in the last year.
Current Stock Price for Organogenesis Hldgs (ORGO)?
The stock price for Organogenesis Hldgs (NASDAQ: ORGO) is $3.22 last updated September 29, 2023 at 9:08 PM UTC.
Does Organogenesis Hldgs (ORGO) pay a dividend?
There is no dividend information for Organogenesis Hldgs.
When is Organogenesis Hldgs (NASDAQ:ORGO) reporting earnings?
Organogenesis Hldgs’s Q3 earnings are confirmed for Wednesday, November 8, 2023.
Is Organogenesis Hldgs (ORGO) going to split?
There is no upcoming split for Organogenesis Hldgs.
What sector and industry does Organogenesis Hldgs (ORGO) operate in?
Organogenesis Hldgs is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Organogenesis Hldgs Stock (NASDAQ:ORGO), Quotes and News Summary
Organogenesis Hldgs Stock (NASDAQ: ORGO) stock price, news, charts, stock research, profile.
| Open3.380 | Close3.180 |
| Vol / Avg.1.269M / 871.745K | Mkt Cap422.824M |
| Day Range3.135 - 3.480 | 52 Wk Range1.795 - 4.500 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | 0.020 | 0.050 | 0.0300 | ||||
| REV | 115.100M | 117.316M | 2.216M |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-08-11 | Morgan Stanley | Drew Ranieri | Maintains | Equal-WeightEqual-Weight | Lowers | 5.00 | 3.00 |
| 2023-08-10 | BTIG | Ryan Zimmerman | Maintains | BuyBuy | Lowers | 10.00 | 4.00 |
| 2023-06-15 | Morgan Stanley | Drew Ranieri | Initiates Coverage On | Equal-Weight | Announces | - | 5.00 |
| 2023-05-24 | BTIG | Ryan Zimmerman | Upgrades | NeutralBuy | Announces | - | 10.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| ORGO | Organogenesis Hldgs | -5.01% | 422.8M |
| RNA | Avidity Biosciences | -3.96% | 466.8M |
| FDMT | 4D Molecular Therapeutics | 0.71% | 535.3M |
| CDNA | CareDx | -0.57% | 379.2M |
| ANAB | AnaptysBio | -0.22% | 476.8M |
How do I buy Organogenesis Hldgs (ORGO) stock?
You can purchase shares of Organogenesis Hldgs (NASDAQ: ORGO) through any online brokerage.
Who are Organogenesis Hldgs's (ORGO) competitors?
Other companies in Organogenesis Hldgs’s space includes: Avidity Biosciences (NASDAQ:RNA), 4D Molecular Therapeutics (NASDAQ:FDMT), CareDx (NASDAQ:CDNA), AnaptysBio (NASDAQ:ANAB) and Agenus (NASDAQ:AGEN).
What is the target price for Organogenesis Hldgs (ORGO) stock?
The latest price target for Organogenesis Hldgs (NASDAQ: ORGO) was reported by Morgan Stanley on Friday, August 11, 2023. The analyst firm set a price target for 3.00 expecting ORGO to fall to within 12 months (a possible -6.83% downside). 5 analyst firms have reported ratings in the last year.
Current Stock Price for Organogenesis Hldgs (ORGO)?
The stock price for Organogenesis Hldgs (NASDAQ: ORGO) is $3.22 last updated September 29, 2023 at 9:08 PM UTC.
Does Organogenesis Hldgs (ORGO) pay a dividend?
There is no dividend information for Organogenesis Hldgs.
When is Organogenesis Hldgs (NASDAQ:ORGO) reporting earnings?
Organogenesis Hldgs’s Q3 earnings are confirmed for Wednesday, November 8, 2023.
Is Organogenesis Hldgs (ORGO) going to split?
There is no upcoming split for Organogenesis Hldgs.
What sector and industry does Organogenesis Hldgs (ORGO) operate in?
Organogenesis Hldgs is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Organogenesis Hldgs Stock (NASDAQ:ORGO), Quotes and News Summary
Organogenesis Hldgs Stock (NASDAQ: ORGO) stock price, news, charts, stock research, profile.
| Open3.380 | Close3.180 |
| Vol / Avg.1.269M / 871.745K | Mkt Cap422.824M |
| Day Range3.135 - 3.480 | 52 Wk Range1.795 - 4.500 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | 0.020 | 0.050 | 0.0300 | ||||
| REV | 115.100M | 117.316M | 2.216M |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-08-11 | Morgan Stanley | Drew Ranieri | Maintains | Equal-WeightEqual-Weight | Lowers | 5.00 | 3.00 |
| 2023-08-10 | BTIG | Ryan Zimmerman | Maintains | BuyBuy | Lowers | 10.00 | 4.00 |
| 2023-06-15 | Morgan Stanley | Drew Ranieri | Initiates Coverage On | Equal-Weight | Announces | - | 5.00 |
| 2023-05-24 | BTIG | Ryan Zimmerman | Upgrades | NeutralBuy | Announces | - | 10.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| ORGO | Organogenesis Hldgs | -5.01% | 422.8M |
| RNA | Avidity Biosciences | -3.96% | 466.8M |
| FDMT | 4D Molecular Therapeutics | 0.71% | 535.3M |
| CDNA | CareDx | -0.57% | 379.2M |
| ANAB | AnaptysBio | -0.22% | 476.8M |
How do I buy Organogenesis Hldgs (ORGO) stock?
You can purchase shares of Organogenesis Hldgs (NASDAQ: ORGO) through any online brokerage.
Who are Organogenesis Hldgs's (ORGO) competitors?
Other companies in Organogenesis Hldgs’s space includes: Avidity Biosciences (NASDAQ:RNA), 4D Molecular Therapeutics (NASDAQ:FDMT), CareDx (NASDAQ:CDNA), AnaptysBio (NASDAQ:ANAB) and Agenus (NASDAQ:AGEN).
What is the target price for Organogenesis Hldgs (ORGO) stock?
The latest price target for Organogenesis Hldgs (NASDAQ: ORGO) was reported by Morgan Stanley on Friday, August 11, 2023. The analyst firm set a price target for 3.00 expecting ORGO to fall to within 12 months (a possible -6.83% downside). 5 analyst firms have reported ratings in the last year.
Current Stock Price for Organogenesis Hldgs (ORGO)?
The stock price for Organogenesis Hldgs (NASDAQ: ORGO) is $3.22 last updated September 29, 2023 at 9:08 PM UTC.
Does Organogenesis Hldgs (ORGO) pay a dividend?
There is no dividend information for Organogenesis Hldgs.
When is Organogenesis Hldgs (NASDAQ:ORGO) reporting earnings?
Organogenesis Hldgs’s Q3 earnings are confirmed for Wednesday, November 8, 2023.
Is Organogenesis Hldgs (ORGO) going to split?
There is no upcoming split for Organogenesis Hldgs.
What sector and industry does Organogenesis Hldgs (ORGO) operate in?
Organogenesis Hldgs is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Organogenesis Hldgs Stock (NASDAQ:ORGO), Quotes and News Summary
Organogenesis Hldgs Stock (NASDAQ: ORGO) stock price, news, charts, stock research, profile.
| Open3.380 | Close3.180 |
| Vol / Avg.1.269M / 871.745K | Mkt Cap422.824M |
| Day Range3.135 - 3.480 | 52 Wk Range1.795 - 4.500 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | 0.020 | 0.050 | 0.0300 | ||||
| REV | 115.100M | 117.316M | 2.216M |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-08-11 | Morgan Stanley | Drew Ranieri | Maintains | Equal-WeightEqual-Weight | Lowers | 5.00 | 3.00 |
| 2023-08-10 | BTIG | Ryan Zimmerman | Maintains | BuyBuy | Lowers | 10.00 | 4.00 |
| 2023-06-15 | Morgan Stanley | Drew Ranieri | Initiates Coverage On | Equal-Weight | Announces | - | 5.00 |
| 2023-05-24 | BTIG | Ryan Zimmerman | Upgrades | NeutralBuy | Announces | - | 10.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| ORGO | Organogenesis Hldgs | -5.01% | 422.8M |
| RNA | Avidity Biosciences | -3.96% | 466.8M |
| FDMT | 4D Molecular Therapeutics | 0.71% | 535.3M |
| CDNA | CareDx | -0.57% | 379.2M |
| ANAB | AnaptysBio | -0.22% | 476.8M |
How do I buy Organogenesis Hldgs (ORGO) stock?
You can purchase shares of Organogenesis Hldgs (NASDAQ: ORGO) through any online brokerage.
Who are Organogenesis Hldgs's (ORGO) competitors?
Other companies in Organogenesis Hldgs’s space includes: Avidity Biosciences (NASDAQ:RNA), 4D Molecular Therapeutics (NASDAQ:FDMT), CareDx (NASDAQ:CDNA), AnaptysBio (NASDAQ:ANAB) and Agenus (NASDAQ:AGEN).
What is the target price for Organogenesis Hldgs (ORGO) stock?
The latest price target for Organogenesis Hldgs (NASDAQ: ORGO) was reported by Morgan Stanley on Friday, August 11, 2023. The analyst firm set a price target for 3.00 expecting ORGO to fall to within 12 months (a possible -6.83% downside). 5 analyst firms have reported ratings in the last year.
Current Stock Price for Organogenesis Hldgs (ORGO)?
The stock price for Organogenesis Hldgs (NASDAQ: ORGO) is $3.22 last updated September 29, 2023 at 9:08 PM UTC.
Does Organogenesis Hldgs (ORGO) pay a dividend?
There is no dividend information for Organogenesis Hldgs.
When is Organogenesis Hldgs (NASDAQ:ORGO) reporting earnings?
Organogenesis Hldgs’s Q3 earnings are confirmed for Wednesday, November 8, 2023.
Is Organogenesis Hldgs (ORGO) going to split?
There is no upcoming split for Organogenesis Hldgs.
What sector and industry does Organogenesis Hldgs (ORGO) operate in?
Organogenesis Hldgs is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Organogenesis Hldgs Stock (NASDAQ:ORGO), Quotes and News Summary
Organogenesis Hldgs Stock (NASDAQ: ORGO) stock price, news, charts, stock research, profile.
| Open3.380 | Close3.180 |
| Vol / Avg.1.269M / 871.745K | Mkt Cap422.824M |
| Day Range3.135 - 3.480 | 52 Wk Range1.795 - 4.500 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | 0.020 | 0.050 | 0.0300 | ||||
| REV | 115.100M | 117.316M | 2.216M |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-08-11 | Morgan Stanley | Drew Ranieri | Maintains | Equal-WeightEqual-Weight | Lowers | 5.00 | 3.00 |
| 2023-08-10 | BTIG | Ryan Zimmerman | Maintains | BuyBuy | Lowers | 10.00 | 4.00 |
| 2023-06-15 | Morgan Stanley | Drew Ranieri | Initiates Coverage On | Equal-Weight | Announces | - | 5.00 |
| 2023-05-24 | BTIG | Ryan Zimmerman | Upgrades | NeutralBuy | Announces | - | 10.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| ORGO | Organogenesis Hldgs | -5.01% | 422.8M |
| RNA | Avidity Biosciences | -3.96% | 466.8M |
| FDMT | 4D Molecular Therapeutics | 0.71% | 535.3M |
| CDNA | CareDx | -0.57% | 379.2M |
| ANAB | AnaptysBio | -0.22% | 476.8M |
How do I buy Organogenesis Hldgs (ORGO) stock?
You can purchase shares of Organogenesis Hldgs (NASDAQ: ORGO) through any online brokerage.
Who are Organogenesis Hldgs's (ORGO) competitors?
Other companies in Organogenesis Hldgs’s space includes: Avidity Biosciences (NASDAQ:RNA), 4D Molecular Therapeutics (NASDAQ:FDMT), CareDx (NASDAQ:CDNA), AnaptysBio (NASDAQ:ANAB) and Agenus (NASDAQ:AGEN).
What is the target price for Organogenesis Hldgs (ORGO) stock?
The latest price target for Organogenesis Hldgs (NASDAQ: ORGO) was reported by Morgan Stanley on Friday, August 11, 2023. The analyst firm set a price target for 3.00 expecting ORGO to fall to within 12 months (a possible -6.83% downside). 5 analyst firms have reported ratings in the last year.
Current Stock Price for Organogenesis Hldgs (ORGO)?
The stock price for Organogenesis Hldgs (NASDAQ: ORGO) is $3.22 last updated September 29, 2023 at 9:08 PM UTC.
Does Organogenesis Hldgs (ORGO) pay a dividend?
There is no dividend information for Organogenesis Hldgs.
When is Organogenesis Hldgs (NASDAQ:ORGO) reporting earnings?
Organogenesis Hldgs’s Q3 earnings are confirmed for Wednesday, November 8, 2023.
Is Organogenesis Hldgs (ORGO) going to split?
There is no upcoming split for Organogenesis Hldgs.
What sector and industry does Organogenesis Hldgs (ORGO) operate in?
Organogenesis Hldgs is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.